AKT1 and central nervous system cancer: Our findings demonstrate that FTO suppresses glioma proliferation and cell cycle progression by regulating the stability of Epiregulin (EREG) mRNA and subsequently inactivating the PI3K/Akt signaling pathway, thereby establishing its role as a key tumor suppressor in glioma.